In the current study, Sr/Fe co-substituted hydroxyapatite
(HAp)
bioceramics were prepared by the sonication-assisted aqueous chemical
precipitation method followed by sintering at 1100 °C for bone
tissue regeneration applications. The sintered bioceramics were analyzed
for various structural and chemical properties through X-ray diffraction,
scanning electron microscopy, and Fourier transform infrared spectroscopy,
which confirmed the phase purity of HAp and Sr/Fe co-substitution
into its lattice. The Vickers hardness measurement, high blood compatibility
(less than 5% hemolysis), and ability to support the adhesion, proliferation,
and osteogenic differentiation of human mesenchymal stem cells suggest
the suitability of Sr/Fe:HAp bioceramics for bone implant applications.
The physicochemical analysis revealed that the developed Sr/Fe:HAp
bioceramics exhibited a polyphasic nature (HAp and βTCP) with
almost identical structural morphology having a particle size less
than 0.8 μm. The dielectric constant (ε′) and dielectric
loss (ε″) were potentially affected by the incorporated
foreign ions together with the polyphasic nature of the material.
The Sr/Fe co-substituted samples demonstrated extended drug (5-fluorouracil
and amoxicillin) release profiles at the pH of physiological medium.
The multifunctional properties of the developed HAp bioceramics enabled
them to be an auspicious candidate for potential biomedical applications,
including targeted drug-delivery applications, heating mediator in
hyperthermia, and bone tissue repair implants.